In this context, recently, genetic studies have shown that IL-33 mRNA levels are not correlated with allele dosage, although genetic polymorphisms in IL-33 contributing to the risk of IBD have been reported2, 4–6, 44. The gene discussed is IL33; the disease is inflammatory bowel disease.